BenevolentAI
BenevolentAI
AI-powered drug discovery company
Machine Learning
Drug Discovery
Bioinformatics
Natural Language Processing
Knowledge Graphs
Open roles at BenevolentAI
0 open roles
No open positions at this time
Products and services
BE
BenevolentAI Drug Discovery Platform
Drug Discovery
AI Drug Discovery Platform
AI Platform
KN
Knowledge Graph
Data Intelligence
BE
BenevolentAI Platform
Drug Discovery Platform
Target Identification Services
Drug Discovery Services
Drug Repurposing Solutions
Drug Discovery Services
Pharmaceutical Partnerships
Partnership Services
Biomedical Knowledge Graph
Data Platform
TA
Target Identification
Drug Discovery Service
Scientific Literature Analysis
AI Platform
DR
Drug Repurposing Platform
Drug Discovery
LI
Literature Mining Tools
AI Tools
CL
Clinical Trial Optimization
Clinical Research Service
PA
Partnership Programs
Partnerships
DR
Drug Repurposing
Drug Discovery Service
Compound Prediction Models
AI Platform
BI
Biomarker Discovery
Diagnostics
CO
Compound Design
Drug Discovery Service
Leadership
JS
Joanna Shields
CEO
Similar companies
Xaira
AI for drug discovery
San Francisco, CA
51-200 employees
Private
Valuation 2.1B
Eli Lilly
Develops medicines for serious and chronic diseases
Indianapolis, Marion County
10,001+ employees
Public
Valuation $588B
359 open jobs
Relay Therapeutics
Relay Therapeutics is a biotechnology company that integrates computational and experimental approaches to discover and develop precision medicines.
Cambridge, MA
201-500 employees
Private
Valuation $3.2B
9 open jobs
Atomwise
AI-powered drug discovery company
San Francisco, CA
51-200 employees
Private
Valuation $3B
Isomorphic Labs
Alphabet AI drug discovery lab (DeepMind spinoff)
London, Greater London
51-200 employees
Private
15 open jobs
Latest updates
All
X
News
HN
YouTube
BenevolentAI And AstraZeneca Collaborate On New Lupus Target Sam O'reilly (hNAB4pTc9p) - Mshale
Mshale
News
·
3 weeks ago
BENEVOLENTAI (BAIVF) holdings - Yahoo Finance Australia
Yahoo Finance Australia
News
·
1 month ago
BenevolentAI And AstraZeneca Collaborate On New Lupus Target Sam O'reilly (hNAB4pTc9p) - Mshale
Mshale
News
·
1 month ago
Amyotrophic Lateral Sclerosis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - Barchart.com
Barchart.com
News
·
2 months ago
Amyotrophic Lateral Sclerosis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - Barchart.com
Barchart.com
News
·
2 months ago
Show 4 more
Total Views
5
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
4.1
10 reviews
Work-life balance
3.2
Compensation
4.0
Culture
4.3
Career
3.5
Management
4.2
75%
Recommend to a friend
Pros
Supportive team and colleagues
Innovative and cutting-edge projects
Good work-life balance and flexibility
Cons
High pressure and stress
Heavy workload and overtime
Limited career advancement
Contact and location